Skip to content

Clinical trials

Phase 2 Scleroderma, Diffuse trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Phase: Phase 2 Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20142
20151
20161
20171
20192
20211
20222
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting4
Terminated2
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
CSL Behring2
United Therapeutics2
Amgen1
Bristol-Myers Squibb1
Daval International Limited1
Dinesh Khanna, MD, MS1
Inventiva Pharma1
Mediar Therapeutics1
Prof. Ariane herrick1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse18
Scleroderma, Systemic7
Lung Diseases, Interstitial2
Autoimmune Diseases1
Fatigue1
Fibrosis1
Immune System Diseases1
Pain1
Renal Insufficiency, Chronic1
Scleroderma, Limited1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.